Anson Funds Management LP - Dec 31, 2024 SCHEDULE 13G Report for TRANSCODE THERAPEUTICS, INC. Common Stock, $0.0001 par value (RNAZ)

Filing Manager
Anson Funds Management LP
Reporting Manager
Anson Funds Management LP
Security
TRANSCODE THERAPEUTICS, INC. Common Stock, $0.0001 par value
Symbol
RNAZ
Shares outstanding
1.15M shares
Disclosed Ownership
113K shares
Ownership
9.9%
Form type
SCHEDULE 13G
Date filed
2/14/2025, 05:16 PM
Date of event
Dec 31, 2024
Next filing
Aug 14, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Anson Funds Management LP 9.9% 113K 0 113K /s/ Tony Moore Manager
Tony Moore 9.9% 113K 0 113K s/ Tony Moore Tony Moore
Anson Advisors Inc. 9.9% 113K 0 113K /s/ Amin Nathoo Director
Amin Nathoo 9.9% 113K 0 113K /s/ Amin Nathoo Amin Nathoo
Moez Kassam 9.9% 113K 0 113K /s/ Moez Kassam Moez Kassam